Results 201 to 210 of about 74,894 (279)

Realizing effectiveness across continents with hydroxyurea: Enrollment and baseline characteristics of the multicenter REACH study in Sub‐Saharan Africa

American journal of hematology/oncology, 2018
Patrick T. McGann, T. Williams, P. Olupot‐Olupot, G. Tomlinson, A. Lane, José Luís Reis da Fonseca, R. Kitenge, G. Mochamah, H. Wabwire, Susan E Stuber, T. Howard, Kathryn E. McElhinney, B. Aygun, Teresa S. Latham, Brígida Santos, L. Tshilolo, R. Ware   +16 more
semanticscholar   +1 more source

Changes in haematological indices among children with sickle cell disease on hydroxyurea treatment for at least 1 year: A cohort study. [PDF]

PLoS One
Emuli S, Tegu C, Oguttu F, Nantale R, Ochieng P, Passi G, Abeso J, Wamulugwa J, Musaba MW, Namazi R, Kiguli S, Mukunya D.   +11 more
europepmc   +1 more source

Sickle-cell disease: a call to action [PDF]

, 2015
Piel, FB, Weatherall, DJ
core   +1 more source

Advances and Gaps in Global Newborn Screening for Sickle Cell Disease. [PDF]

Int J Neonatal Screen
Shook LM, Ware RE.
europepmc   +1 more source

Hydroxyurea therapy [PDF]

Blood, 2014
openaire   +1 more source

Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography. [PDF]

, 2017
Anderson, Nina, Ballas, Samir K., Eckman, James R.   +2 more
core   +2 more sources

Tofacitinib Use in a Patient With Rheumatoid Arthritis and Polycythemia Vera: A Case Report. [PDF]

Clin Case Rep
Bogojevic M, Medjedovic R, Markovic M, Bakic N, Pravilovic Lutovac D.   +4 more
europepmc   +1 more source

Hydroxyurea Therapy in Sickle Cell Disease: Evaluating Healthcare Costs and Utilization in a Brazilian Tertiary Setting. [PDF]

Blood Glob Hematol
Browne LLA, do Nascimento EM, Moura P, Fidlarczyk D, Duran J, Barbosa R, Oliveira T, Goshua G, Hankins JS, Lobo C.   +9 more
europepmc   +1 more source

Randomized feasibility trial to improve hydroxyurea adherence in youth ages 10–18 years through community health workers: The HABIT study

Pediatric Blood & Cancer, 2017
N. Green, D. Manwani, Sérgio Matos, April Hicks, Luisa Soto, Yina Castillo, K. Ireland, Yvonne Stennett, S. Findley, Haomiao Jia, A. Smaldone   +10 more
semanticscholar   +1 more source

Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyurea. [PDF]

Blood Adv
Haggenburg S, Pothast CR, Hofsink Q, Haverkate NJE, Bhoekhan MS, Claireaux M, van Binnendijk RS, Hartog GD, Lissenberg-Witte BI, de Vries RD, van Tuijn C, Biemond BJ, Nur E, Geurts van Kessel CH, Mutsaers PGNJ, Broers AEC, Goorhuis A, Nijhof IS, van Gils MJ, Heemskerk MHM, Hazenberg MD, Rutten CE, van Meerloo JJH, Smit GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra N, Kant IMJ, Graas T, Toussaint B, de Jong S, Darwesh S, Mahes SS, Kamminga D, Koelewijn M, Faber G, Beaumont G, Engel MD, Pierie RCN, Janssen SR, Faber G, Groen K, Burger JA, Bouhuijs JH, Baars PA, van Dijkman E, Heijmans J, Witte YY, Nahui Palomino RA, Omar SZ, Zweegman S, Kater AP, van den Vegt C, Arends-Halbesma I, de Pater E, Dijkstra MJ, van Beek J, Rots NY, Rijnstra ES, de Rooij DM, Sanders RW, Poniman M, Olijhoek W, van Rijswijk J, Beaumont T, Çetinel L, Schellekens L, den Hartogh YM, Cloos J, Weijers SS, Tonouh-Aajoud S, Avci S, Roelandse-Koop E, Dik WA, Vogels-Nooijen S.   +75 more
europepmc   +1 more source